What is the quality, capacity and efficiency of running clinical trials in Puerto Rico? In this discussion we speak with Dr Myrto Lee, Director, PwC's Strategy&, UK and Dr Kosmas Kretsos, Executive Director of the Puerto Rico Consortium for Clinical Investigation to learn about key initiatives and outcomes so far to make running clinical trials more attractive in Puerto Rico. For more information about conducting clinical trials in Puerto Rico, please visit www.PRCCI.org.

Why consider Puerto Rico for clinical trials?
Status of new sites to expand clinical trial networks
Status of a central coordinator with sites to reduce bureaucracy e.g. central IRB, central invoicing
Patient access and costs
Patient engagement
Access to new technologies
Training

Guest Host:

Dr Myrto Lee, Director, PwC's Strategy&, UK

Guest:

Dr Kosmas Kretsos, Executive Director, PRCCI (Puerto Rico Consortium for Clinical Investigation), Puerto Rico

Producer:

Valerie Bowling, Executive Director, the Conference Forum

Clinical Trial Opportunities in Puerto Rico

Share

Embed